Lupin has launched its new Adhero connected inhaler monitoring device in India, the company said. According to Lupin, the company collaborated with Aptar Pharma on the device, which attaches to the tops of MDIs.
The Adhero sensors allow for monitoring of inhaler use, and data are uploaded to a “MyAdhero” app via Bluetooth. The usage data are also accessible to health care professionals. In addition to monitoring, the app can also provide the patient with prompts such as reminders to use their inhaler and alerts for risks such as poor air quality in their area.
Lupin President India Region Formulations Rajeev Sibal commented, “Lupin lays great emphasis on three aspects of respiratory medicine, namely disease awareness, diagnosis and adherence. The launch of Adhero will be a great help to patients using metered dose inhalers, as well as, for doctors to track adherence and compliance to therapy, thereby improving clinical outcomes and quality of life of patients.”
Read the Lupin press release.
